Live-cell imaging of cell-to-cell variability in caspase-8 FRET reporter activity and cell fate trajectory modeling - Dataset (ID:20232)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Protein | Protein Concentration | Protein Conc Unit | Antibody Name | Antibody Concentration | Antibody Conc Unit | 2nd Antibody Name | 2nd Antibody Concentration | 2nd Antibody Conc Unit | Replicate | Mean log10(k) (a.u.) | Mean tau (min) | Surviving Fraction | Classification Accuracy (theta_T) | Classification Accuracy (fate boundary) |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
HeLa ICRP | Apomab | 25.0 | nM | 3 | -6.37 | 263.5100 | 0.877 | 0.87966 | 0.88252 | |||||||||
HeLa ICRP | Apomab | 25.0 | nM | 6 | -6.53 | 267.1805 | 0.838 | 0.85338 | 0.84962 | |||||||||
HeLa ICRP | Apomab | 50.0 | nM | 1 | -6.39 | 285.0388 | 0.953 | 0.95349 | 0.85271 | |||||||||
HeLa ICRP | Apomab | 100.0 | nM | 1 | -6.13 | 217.8947 | 0.934 | 0.92763 | 0.77632 | |||||||||
HeLa ICRP | Apomab | 100.0 | nM | 2 | -6.31 | 231.7647 | 0.971 | 0.98529 | 0.85294 | |||||||||
HeLa ICRP | Apomab | 25.0 | nM | anti-Fc | 25.0 | nM | 1 | -5.57 | 236.0268 | 0.848 | 0.90179 | 0.77679 | ||||||
HeLa ICRP | Apomab | 25.0 | nM | anti-Fc | 25.0 | nM | 2 | -5.70 | 239.2890 | 0.839 | 0.94037 | 0.83028 | ||||||
HeLa ICRP | Apomab | 25.0 | nM | anti-Fc | 25.0 | nM | 4 | -6.12 | 272.4815 | 0.907 | 0.92963 | 0.88889 | ||||||
HeLa ICRP | Apomab | 25.0 | nM | anti-Fc | 25.0 | nM | 5 | -6.31 | 302.5813 | 0.872 | 0.90672 | 0.84816 | ||||||
HeLa ICRP | Apomab | 50.0 | nM | anti-Fc | 50.0 | nM | 2 | -5.58 | 216.2613 | 0.820 | 0.96396 | 0.81532 | ||||||
HeLa ICRP | Apomab | 100.0 | nM | anti-Fc | 100.0 | nM | 1 | -5.59 | 246.1950 | 0.843 | 0.91195 | 0.75472 | ||||||
HeLa ICRP | Bortezomib | 100 | nM | Mapatumumab | 10.0 | nM | anti-Fc | 10.0 | nM | 2 | -4.93 | 186.2624 | 0.010 | 0.90759 | 0.68812 | |||
HeLa ICRP | Bortezomib | 100 | nM | Mapatumumab | 10.0 | nM | 1 | -5.47 | 338.7050 | 0.034 | 0.89448 | 0.31894 | ||||||
HeLa ICRP | Mapatumumab | 200.0 | nM | anti-Fc | 200.0 | nM | 2 | -4.69 | 101.5925 | 0.438 | 0.79391 | 0.66979 | ||||||
HeLa ICRP | Bortezomib | 100 | nM | Mapatumumab | 10.0 | nM | 2 | -5.47 | 319.6967 | 0.075 | 0.86936 | 0.30949 | ||||||
HeLa ICRP | Mapatumumab | 100.0 | nM | anti-Fc | 100.0 | nM | 1 | -4.50 | 87.7636 | 0.273 | 0.80364 | 0.73091 | ||||||
HeLa ICRP | Mapatumumab | 10.0 | nM | anti-Fc | 10.0 | nM | 3 | -4.68 | 110.9162 | 0.288 | 0.84817 | 0.79581 | ||||||
HeLa ICRP | Mapatumumab | 10.0 | nM | anti-Fc | 10.0 | nM | 2 | -4.63 | 107.8715 | 0.406 | 0.74559 | 0.66751 | ||||||
HeLa ICRP | Mapatumumab | 25.0 | nM | anti-Fc | 25.0 | nM | 1 | -4.50 | 85.1585 | 0.268 | 0.73592 | 0.70775 | ||||||
HeLa ICRP | Mapatumumab | 25.0 | nM | anti-Fc | 25.0 | nM | 2 | -4.55 | 92.1239 | 0.381 | 0.66372 | 0.64307 | ||||||
HeLa ICRP | Mapatumumab | 25.0 | nM | anti-Fc | 25.0 | nM | 3 | -4.54 | 92.8286 | 0.238 | 0.83860 | 0.78369 | ||||||
HeLa ICRP | Mapatumumab | 100.0 | nM | anti-Fc | 100.0 | nM | 2 | -4.57 | 88.4746 | 0.369 | 0.65085 | 0.66780 | ||||||
HeLa ICRP | Mapatumumab | 5.0 | nM | anti-Fc | 5.0 | nM | 2 | -4.93 | 153.1692 | 0.347 | 0.89079 | 0.76445 | ||||||
HeLa ICRP | Mapatumumab | 5.0 | nM | anti-Fc | 5.0 | nM | 1 | -4.80 | 134.6580 | 0.476 | 0.71010 | 0.61238 | ||||||
HeLa ICRP | Mapatumumab | 5.0 | nM | anti-Fc | 5.0 | nM | 3 | -4.94 | 145.1482 | 0.550 | 0.82210 | 0.67925 |